Kornitzer Capital Management’s Corcept Therapeutics CORT Stock Holding History

Kornitzer Capital Management’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.23M	Buy	+83,110	New	+$5.02M	0.15%	139

Other funds holding CORT

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

FWP

FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Kornitzer Capital Management's CORT Position: Q2 2026 in Review

Kornitzer Capital Management opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 83,110 shares worth $7.23M. The stake represents 0.15% of the portfolio and ranks #139 among its holdings.

113 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

Kornitzer Capital Management held 83,110 shares of Corcept Therapeutics worth $7.23M as of Q2 2026.
Corcept Therapeutics was a new Kornitzer Capital Management position in Q2 2026.
Corcept Therapeutics made up 0.15% of Kornitzer Capital Management's portfolio in Q2 2026, its #139 holding.
113 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Kornitzer Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.